FDA Approves Cohera’s Tissue Adhesive For Use in Stomach Surgery

Feb. 6, 2015, 10:12 PM UTC

The Food and Drug Administration said Feb. 4 it approved the first tissue adhesive approved for internal use.

The adhesive, known as TissuGlu, is urethane-based and allows a surgeon “to connect tissue flaps made during surgery to remove excess fat and skin or to restore weakened or separated abdominal muscles (abdominoplasty surgery),” the FDA said in a statement. Attaching tissue flaps with internal adhesive may reduce or eliminate the need for postoperative surgical draining of fluid found between abdominoplasty tissue flaps, the statement also said.

Pittsburgh-based Cohera Medical Inc. manufactures TissuGlu.

Before the FDA announcement, the company Jan. 6 received ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.